Evidence map›Paper›PMID 35851035›Full record

ArticleArchives of disease in childhood. Fetal and neonatal edition2022

A randomised trial comparing weaning from CPAP alone with weaning using heated humidified high flow nasal cannula in very preterm infants: the CHiPS study.

Joanne Clements, Pernille M Christensen, Michael Meyer

Open access · hybridAbstract read
In one paragraph

Article in Archives of disease in childhood. Fetal and neonatal edition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Joanne ClementsNeonatal Unit, Middlemore Hospital, Counties Manukau DHB, Auckland, New Zealand joanne.clements@middlemore.co.nz.ORCID http://orcid.org/0000-0003-1325-2517
Pernille M ChristensenResearch & Evaluation Office, KoAwatea, Counties Manukau DHB, Auckland, New Zealand.
Michael MeyerNeonatal Unit, Middlemore Hospital, Counties Manukau DHB, Auckland, New Zealand.
Counties Manukau District Health Board · NZMiddlemore Hospital · NZUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether weaning from nasal continuous positive airway pressure (nCPAP) using heated humidified high flow nasal cannula (nHF) was non-inferior to weaning using nCPAP alone in relation to time on respiratory support. STUDY

designSingle-centre, non-inferiority, randomised controlled trial.

settingNeonatal Intensive Care Unit, Middlemore Hospital, Auckland, New Zealand. PATIENTS: 120 preterm infants, <30 weeks' gestation at birth, stable on nCPAP for at least 48 hours.

interventionsInfants underwent stratified randomisation to nHF 6 L/min or bubble CPAP 6 cm water. In both groups, stepwise weaning of their respiratory support over 96 hours according to a strict weaning protocol was carried out.

main outcome measuresTime on respiratory support from randomisation to 72 hours off respiratory support or 36 weeks' postmenstrual age. The non-inferiority threshold was set at 15%.

results59 infants were randomised to weaning using nHF and 61 using nCPAP. The groups were well balanced in regards to baseline demographics. The restricted mean duration of respiratory support following randomisation for the nCPAP group, using per-protocol analysis was 401 hours (upper boundary, mean plus 0.15, was 461 hours) and 375 hours in the nHF group (upper 95% CI 413 hours). nHF weaning was, therefore, non-inferior to nCPAP weaning at the non-inferiority threshold. There was no significant difference in time to discharge.

conclusionFor infants ready to wean from nCPAP, the CHiPS study found that nHF was non-inferior to discontinuing nCPAP at 5 cm water. TRIAL REGISTRATION NUMBER: Australia and New Zealand Clinical Trials Registry (ACTRN12615000077561).

Indexed as

neonatologyrespiratory

Identifiers

PMID35851035
PMCPMC9763181
OpenAlexW4285730719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.